All In Biotech

Drug Trial Radar · NCT02680756

Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD

A Phase 3b, Randomized, Controlled, Multicentre Study With Oral Ferric Maltol (Feraccru) or Intravenous Iron (Ferric Carboxy Maltose; FCM), for the Treatment of Iron Deficiency Anaemia in Subjects With Inflammatory Bowel Disease

Last checked: Nov 20, 2026Latest source record: Nov 2, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 250 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

250

Actual

Start

Jan 2016

Primary completion

Oct 2018

Study completion Jan 2019

Sponsor

Lead sponsor
Shield TherapeuticsIndustry
Sponsor type
Industry
First posted
Feb 11, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of haemoglobin in subjects with Inflammatory Bowel Disease (IBD).

Conditions

  • Anemia, Iron-Deficiency
  • Inflammatory Bowel Disease
  • Crohn's Disease

Interventions

  • Ferric MaltolDrug

  • Ferric Carboxy MaltoseDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects Achieving Either a 2g/dL Increase in Hb OR Normalization of Hb at Week 12Time frame: Baseline to Week 12
  2. Number of Subjects Achieving Either a 2g/dL Increase in Hb OR Normalization of Hb at Week 12Time frame: Baseline to Week 12

Locations

44 sites in 6 countries. Site status is shown where the registry gives one.

  • Site not named

    Dothan, Alabama

  • Site not named

    Tucson, Arizona

  • Site not named

    Gainesville, Florida

  • Site not named

    Hollywood, Florida

  • Site not named

    Chevy Chase, Maryland

  • Site not named

    Saint Paul, Minnesota

  • Site not named

    St Louis, Missouri

  • Site not named

    Great Neck, New York

  • Site not named

    Lima, Ohio

  • Site not named

    Germantown, Tennessee

  • Site not named

    Nashville, Tennessee

  • Site not named

    Beaumont, Texas

  • Site not named

    Houston, Texas

  • Site not named

    San Antonio, Texas

  • Site not named

    Bountiful, Utah

  • Site not named

    Bellevue, Washington

  • Site not named

    Seattle, Washington

  • Site not named

    Ghent, Belgium

  • Site not named

    Clichy, France

  • Site not named

    Lille, France

  • Site not named

    Lyon, France

  • Site not named

    Saint-Etienne, France

  • Site not named

    Salouël, France

  • Site not named

    Vandœuvre-lès-Nancy, France

  • Site not named

    Berlin, Germany

  • Site not named

    Dresden, Germany

  • Site not named

    Hamburg, Germany

  • Site not named

    Herne, Germany

  • Site not named

    Jena, Germany

  • Site not named

    Leipzig, Germany

  • Site not named

    Lübeck, Germany

  • Site not named

    Lüneburg, Germany

  • Site not named

    Minden, Germany

  • Site not named

    Oldenburg, Germany

  • Site not named

    Schweinfurt, Germany

  • Site not named

    Budapest, Hungary

  • Site not named

    Miskolc, Hungary

  • Site not named

    Szeged, Hungary

  • Site not named

    Barcelona, Spain

  • Site not named

    Córdoba, Spain

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.